Topiramate-induced somnambulism in a migraineur: a probable idiosyncratic adverse effect

Somnambulism (sleepwalking) is a disorder of arousal that falls under "parasomnia" group and is more common in children. These phenomena occur as primary sleep events or secondary to systemic disease or can be drug induced. Medications that can cause sleepwalking include neuroleptics, hypn...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical sleep medicine 2012-04, Vol.8 (2), p.197-198
Main Authors: Mathew, Thomas, Sarma, G R K, Nadig, Raghunandan, Varghese, Raji
Format: Article
Language:English
Subjects:
Adult
Female
Fructose - adverse effects
Fructose - analogs & derivatives
Fructose - therapeutic use
Humans
Migraine Disorders - drug therapy
Neuroprotective Agents - adverse effects
Neuroprotective Agents - therapeutic use
New Research
Somnambulism - chemically induced
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Somnambulism (sleepwalking) is a disorder of arousal that falls under "parasomnia" group and is more common in children. These phenomena occur as primary sleep events or secondary to systemic disease or can be drug induced. Medications that can cause sleepwalking include neuroleptics, hypnotics, lithium, amitriptyline, and β-blockers. This report presents an unusual adverse effect of topiramate on sleep in a patient with migraine.
ISSN:1550-9389
1550-9397
DOI:10.5664/jcsm.1782